TLDR:
- Korean startup Prevenotics secures bridge investment from 500 Global for AI-based cancer prevention technology
- Prevenotics aims to commercialize AI solution for stomach cancer prevention and expand to other types of cancer prevention
Korean startup Prevenotics, specializing in AI-based cancer prevention technology, has secured a bridge investment from global venture capital firm 500 Global. The investment highlights the growing importance of AI in the healthcare sector. Led by CEO Jang Soo-yeon, Prevenotics focuses on endoscopic real-time diagnosis technology and patient management support, with a focus on cancer prevention from the pre-cancer stage. With the recent acquisition of a level 2 medical device certification for its endoscopic image analysis software, Prevenotics plans to commercialize its AI solution for stomach cancer prevention. The company also has ambitious plans to build a comprehensive cancer prevention ecosystem by expanding to colon and liver cancer prevention.
500 Global, a multi-stage venture capital firm with a global presence, sees potential in Prevenotics’ technology that targets and preventively diagnoses diseases at an early stage. The firm believes that Prevenotics’ software, developed using Korea’s endoscopy data, can make a significant impact in preventing stomach cancer in high-risk populations. Since establishing its first Korean fund in 2015, 500 Global has actively supported early-stage startups in Korea to succeed globally. The investment in Prevenotics showcases the convergence of AI and healthcare, demonstrating how technological advancements are transforming disease prevention and management.
This investment not only validates Prevenotics’ innovative approach to cancer prevention but also signifies the growing role of AI in revolutionizing healthcare. With further developments and commercialization of its AI solutions, Prevenotics aims to make a tangible impact in preventing various types of cancer, ultimately contributing to improved public health outcomes. The partnership between Prevenotics and 500 Global sets a strong foundation for future growth and innovation in the Korean startup ecosystem.
